EGFR and neoplasm: Second, we attempted to translate this technology to clinical diagnosis, and demonstrated that mutant plasma EGFR (pEGFR) concentration determined by ddPCR analysis could achieve a concordance of 86.73% with tumor EGFR (tEGFR) status [13].